AU2001269785A1 - Method of treatment of obesity and paralyzed muscle and ergogenic aids - Google Patents

Method of treatment of obesity and paralyzed muscle and ergogenic aids

Info

Publication number
AU2001269785A1
AU2001269785A1 AU2001269785A AU6978501A AU2001269785A1 AU 2001269785 A1 AU2001269785 A1 AU 2001269785A1 AU 2001269785 A AU2001269785 A AU 2001269785A AU 6978501 A AU6978501 A AU 6978501A AU 2001269785 A1 AU2001269785 A1 AU 2001269785A1
Authority
AU
Australia
Prior art keywords
obesity
treatment
paralyzed muscle
ergogenic aids
ergogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269785A
Inventor
William Winder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of AU2001269785A1 publication Critical patent/AU2001269785A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001269785A 2000-06-09 2001-06-11 Method of treatment of obesity and paralyzed muscle and ergogenic aids Abandoned AU2001269785A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21070800P 2000-06-09 2000-06-09
US60210708 2000-06-09
PCT/US2001/018812 WO2001093874A1 (en) 2000-06-09 2001-06-11 Method of treatment of obesity and paralyzed muscle and ergogenic aids

Publications (1)

Publication Number Publication Date
AU2001269785A1 true AU2001269785A1 (en) 2001-12-17

Family

ID=22783952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269785A Abandoned AU2001269785A1 (en) 2000-06-09 2001-06-11 Method of treatment of obesity and paralyzed muscle and ergogenic aids

Country Status (3)

Country Link
EP (1) EP1427425A4 (en)
AU (1) AU2001269785A1 (en)
WO (1) WO2001093874A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192495B1 (en) 2002-03-21 2005-02-16 Universidad De Barcelona NEW THERAPEUTIC USE OF RIBOSIDE 5-AMINOIMIDAZOL-4-CARBOXAMIDE (ACADESIN).
DE602004016503D1 (en) * 2003-06-17 2008-10-23 Medical Res Council METHOD FOR TESTING THE LKB1 PHOSPHORYLING ACTIVITY
US20070213295A1 (en) * 2006-01-16 2007-09-13 The Board Of Regents Of The University Of Texas System Methods and compositions for inducing torpor in a subject
AU2007341981A1 (en) 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Methods for enhancing exercise performance
EP2234622A4 (en) * 2007-12-28 2011-03-09 Salk Inst For Biological Studi Methods for enhancing muscle performance and tone
US20140065099A1 (en) * 2011-02-15 2014-03-06 Ecole Polytechnique Federale De Lausanne (Epfl) Methods of Treating Mitochondrial Dysfunction
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
JP7376951B2 (en) * 2018-08-06 2023-11-09 スカイラーク バイオサイエンス エルエルシー AMP-activated protein kinase activating compounds and uses thereof
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658889A (en) * 1989-01-24 1997-08-19 Gensia Pharmaceuticals, Inc. Method and compounds for aica riboside delivery and for lowering blood glucose
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
AU7629200A (en) * 1999-08-09 2001-03-05 Trustees Of Boston University Method of maintaining vascular integrity using aicar (5-amino-4-imidazole riboside) and related compounds
AU2001268236A1 (en) * 2000-06-06 2001-12-17 Trustees Of Boston University Use of aicar and related compounds

Also Published As

Publication number Publication date
WO2001093874A1 (en) 2001-12-13
EP1427425A1 (en) 2004-06-16
EP1427425A4 (en) 2006-04-05

Similar Documents

Publication Publication Date Title
AU2003287436A1 (en) Apparatus and methods for treatment of morbid obesity
AU2003219934A1 (en) Method of treatment or prevention of obesity
AU7325601A (en) Methods of producing weight loss and treatment of obesity
AU2002356050A1 (en) Method and apparatus for treatment of patients
AU2003216363A1 (en) Massager and method of using same
AU2003287708A1 (en) Active muscle assistance device and method
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU2002367732A1 (en) Method for diagnosis and treatment of rheumatoid arthritis
AU2002351378A1 (en) Method and apparatus for treatment of amblyopia
AU2003291700A1 (en) Oral hygiene system and method of treatment
AU2002230840A1 (en) Apparatus and method for thermal treatment of class
AU2001286983A1 (en) Method of treatment
AU2001278981A1 (en) Prevention and treatment of sexual arousal disorders
AU5739800A (en) Method for direct diagnosis and treatment of pain of muscular origin
AU2001269785A1 (en) Method of treatment of obesity and paralyzed muscle and ergogenic aids
AU7750100A (en) Method for the treatment of obesity
AU2002320171A1 (en) Method and apparatus for treatment of waste
AU2003221005A1 (en) Method of wastewater treatment
AU2001262177A1 (en) Method of treatment
AUPR731901A0 (en) Method of treatment
AU2002212485A1 (en) Method and apparatus for the treatment of sludge
AUPR537101A0 (en) A method of assessment and treatment
AU2003213256A1 (en) Treatment and prevention of aids progression and methods of using same
AU2002311351A1 (en) Use of sodium nucleospermate for treating aids and treatment method
AU2002323430A1 (en) Methods of treating obesity